Theriva Biologics, Inc. (TOVX) Tops Q2 EPS by 2c

Theriva Biologics, Inc. (NYSE: TOVX) reported Q2 EPS of ($0.34), $0.02 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Theriva Biologics, Inc. (TOVX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance